Braxford Journal

Meticulously accurate unadulterated publications

Omega-3 fatty acids

Paragraph on medicine’s history.

Paragraph on medicine’s current usage.

  • Can improve:
    • asthma [ a ]
    • attention deficit hyperactivity disorder [ a ]
    • cancer [ a | f ]
    • cardiovascular health [ b | c | d ]
    • chemotherapy adjunct [ a ]
    • depression [ a ]
    • diabetic retinopathy [ a ]
    • epilepsy [ a ]
    • hyperlipidemia [ a ]
    • hypertriglyceridemia [ a ]
    • intervertebral disc degeneration [ a ]
    • menopausal night sweats [ a ]
    • non-alcoholic fatty liver disease [ a ]
    • periodontal disease [ a ]
    • premenstrual syndrome [ a ]
    • rheumatoid arthritis [ a | f ]
    • type 2 diabetes [ a ]
  • Can prevent:
    • Alzheimer’s disease [ a ]
    • cancer [ a ]
    • cardiovascular disease [ a ]
    • dementia [ a ]
    • heart failure [ a ]
  • Reduces:
    • atherosclerotic plaques [ f ]
    • inflammation [ f | g ]
    • tumor size/growth [ f ]
  • Increases:
    • muscle strength [ e ]
  • Side-effects:
    • arthralgia (joint pain) [ a ]
    • dyspepsia [ a ]
    • diarrhea [ a ]
    • gas [ a ]
    • nausea [ a ]
  • Safety profile (C):
    • Safe [ a ]
    • Negative:
      • an increased risk of atrial fibrillation was observed in patients in the omega-3 fatty acid group [ d ]
      • may increase the risk of stroke in patients with myocardial infarction [ d ]
      • prescription EPA ethyl ester has a high risk of bleeding [ d ]
      • caution and periodic monitoring are recommended in patients taking antiplatelet and anticoagulant medication due to the ability of omega-3 fatty acids to reduce platelet activity [ a ]

Dosage

Low1,000 mg/d of combination DHA plus EPA for 12 weeks or longer [ c ]
Moderate1,000-1,500 mg/d EPA plus DHA as triglycerides for at least 12 weeks [ c ]
Max3 g/d [ a ]

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *